Robartan Tablet 10/160 mg

Adult dose

This drug is administered only to adults, with Valsartan recommended at an oral dose of 80 mg once daily. In cases of poorly controlled blood pressure, the dose can be increased to 160 mg daily, and can be increased up to a maximum of 320 mg. For elderly patients (75 years and older) and those with kidney impairment, fluid depletion, or liver impairment, starting dose is 40 mg once daily. In cases of heart failure, the initial dose is recommended at 40 mg orally twice daily.

Child dose

Safety and effectiveness have not been established in children and adolescents under 18 years of age, and it should not be administered.

This drug can cause serious harm to the fetus when used during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Women of childbearing potential should ensure appropriate contraception before taking this drug, and it must not be used during pregnancy. Patients with severe liver or kidney dysfunction, a history of angioedema, or myopathy cannot take this drug. Elderly patients or those with high serum potassium levels or liver impairment should take this drug with special caution and may require regular monitoring. This drug may cause muscular side effects such as myalgia, myopathy, and, rarely, rhabdomyolysis, so if muscle pain or weakness occurs, medical personnel must be informed immediately. Symptoms such as abnormal liver function, dyspepsia, headache, dizziness, and nausea may occur, and if severe symptoms arise, usage should cease and a doctor should be consulted. Interactions may occur when taken with other medications, so if other drugs are being taken, they must be disclosed, especially when used with potassium-sparing diuretics, certain antibiotics, or fibrate class medications. This drug is not recommended for breastfeeding women; during breastfeeding, either the drug should be avoided, or breastfeeding should be stopped. In case of overdose, contact medical personnel immediately and receive needed treatment, as there is no specific antidote and symptom-based treatment is important. Safety for children and adolescents has not been established, and it is advisable not to administer to those under 18 years of age. Patients are advised to regularly monitor blood pressure, liver function, kidney function, and blood tests during treatment. Keep this drug in a place inaccessible to children and avoid transferring it to another container.

Serious side effects

Hives, severe swelling (edema), angioedema, severe allergic reactions, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin reactions, difficulty breathing, asthma attacks, respiratory issues along with cough+fever, jaundice (yellowing of skin or eyes), extreme lethargy, liver dysfunction (jaundice), sudden and severe headache, thunderclap headache, seizures.

Mild side effects

Dyspepsia, nausea, dizziness, headache, conjunctival hemorrhage, constipation, asthenia, chest pain, facial edema, peripheral edema, nasopharyngitis, urinary tract infection, bruising, increased serum aminotransferases (AST, ALT), increased serum creatine phosphokinase, increased serum potassium, increased gamma-glutamyl transferase, musculoskeletal stiffness, limb pain, decreased sensation, anxiety, upper respiratory infection, edema, insomnia, redness, decreased libido.

This drug may be sensitive to light, so it should be stored in a tightly sealed container that blocks light. Additionally, it is recommended to store the drug at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help ensure the effectiveness of the drug.

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP) * 3]